228 related articles for article (PubMed ID: 27793213)
21. Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
Wu D; Hu S; Hou Y; He Y; Liu S
BMC Cancer; 2020 Mar; 20(1):199. PubMed ID: 32164602
[TBL] [Abstract][Full Text] [Related]
22. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
[TBL] [Abstract][Full Text] [Related]
23. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
[TBL] [Abstract][Full Text] [Related]
24. FN1, GALE, MET, and QPCT overexpression in papillary thyroid carcinoma: molecular analysis using frozen tissue and routine fine-needle aspiration biopsy samples.
da Silveira Mitteldorf CA; de Sousa-Canavez JM; Leite KR; Massumoto C; Camara-Lopes LH
Diagn Cytopathol; 2011 Aug; 39(8):556-61. PubMed ID: 20607686
[TBL] [Abstract][Full Text] [Related]
25. CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.
Li W; Xia S; Aronova A; Min IM; Verma A; Scognamiglio T; Gray KD; Ullmann TM; Liang H; Moore MD; Elemento O; Zarnegar R; Fahey TJ
J Surg Oncol; 2018 Nov; 118(6):1042-1049. PubMed ID: 30311656
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma.
Igci YZ; Arslan A; Akarsu E; Erkilic S; Igci M; Oztuzcu S; Cengiz B; Gogebakan B; Cakmak EA; Demiryurek AT
Endocr Pathol; 2011 Jun; 22(2):86-96. PubMed ID: 21509594
[TBL] [Abstract][Full Text] [Related]
28. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
[TBL] [Abstract][Full Text] [Related]
29. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
30. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
31. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
[TBL] [Abstract][Full Text] [Related]
32. A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study.
González HE; Martínez JR; Vargas-Salas S; Solar A; Veliz L; Cruz F; Arias T; Loyola S; Horvath E; Tala H; Traipe E; Meneses M; Marín L; Wohllk N; Diaz RE; Véliz J; Pineda P; Arroyo P; Mena N; Bracamonte M; Miranda G; Bruce E; Urra S
Thyroid; 2017 Aug; 27(8):1058-1067. PubMed ID: 28521616
[TBL] [Abstract][Full Text] [Related]
33. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
Miseikyte-Kaubriene E; Ulys A; Trakymas M
Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
[TBL] [Abstract][Full Text] [Related]
34. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
[No Abstract] [Full Text] [Related]
35. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
36. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.
Ke Z; Liu Y; Zhang Y; Li J; Kuang M; Peng S; Liang J; Yu S; Su L; Chen L; Sun C; Li B; Cao J; Lv W; Xiao H
Oncol Rep; 2018 Aug; 40(2):659-668. PubMed ID: 29901149
[TBL] [Abstract][Full Text] [Related]
38. Discrimination of benign and malignant thyroid nodules by molecular profiling.
Finley DJ; Zhu B; Barden CB; Fahey TJ
Ann Surg; 2004 Sep; 240(3):425-36; discussion 436-7. PubMed ID: 15319714
[TBL] [Abstract][Full Text] [Related]
39. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.
Lappinga PJ; Kip NS; Jin L; Lloyd RV; Henry MR; Zhang J; Nassar A
Cancer Cytopathol; 2010 Oct; 118(5):287-97. PubMed ID: 20597139
[TBL] [Abstract][Full Text] [Related]
40. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
